Investors in i3 Verticals (NASDAQ:IIIV) have seen returns of 25% over the past five years
It might be of some concern to shareholders to see the i3 Verticals, Inc. (NASDAQ:IIIV) share price down 11% in the last month. But at least the stock is up over the last five years. Unfortunately its return of 25% is below the market return of 138%.
So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.
i3 Verticals isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.
In the last 5 years i3 Verticals saw its revenue grow at 4.8% per year. Put simply, that growth rate fails to impress. It's probably fair to say that the modest growth is reflected in the modest share price gain of 5% per year. If profitability is likely in the near term, then this might be one to add to your watchlist.
The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).
We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. So we recommend checking out this free report showing consensus forecasts
It's good to see that i3 Verticals has rewarded shareholders with a total shareholder return of 12% in the last twelve months. That's better than the annualised return of 5% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. If you want to research this stock further, the data on insider buying is an obvious place to start. You can click here to see who has been buying shares - and the price they paid.
i3 Verticals is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating
Insmed Incorporated (NASDAQ:INSM) is . On June 11, Goldman Sachs analyst Andrea Tan reiterated a 'Buy' rating on the stock and increased the price target to $112 from $100. The adjustment underscores the analyst's confidence about the company's long-term prospects. A scientist examining the glucocerebrosidase enzyme development with the aim of establishing therapeutics for Gaucher disease. The Buy rating comes on the heels of the biopharmaceutical company raising $750 million in a public offering of common stock. It plans to use net proceeds from the offering to accelerate research and development efforts of brensocatib. Part of the funds will also finance the commercialization activities of ARIKAYCE. They will also support the development of treprostinil palmitil inhalation powder and other research initiatives. Insmed Incorporated (NASDAQ:INSM) is a global biopharmaceutical company focused on developing and commercializing therapeutics for serious and rare diseases. It focuses on respiratory and rare diseases, specifically emphasizing metabolic diseases and endocrine disorders. While we acknowledge the potential of INSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Stocks Analysts Are Upgrading Today and 13 Best AI Stocks to Buy Under $10. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CNBC
35 minutes ago
- CNBC
CNBC Daily Open: Iran's desire for a ceasefire lifts U.S. markets, but could be one-sided
The U.S. stock market rose amid news that Iran wants a ceasefire with Israel. As early as the first days of Israel's strikes, Tehran asked several countries to persuade U.S. President Donald Trump to call on Israel for an immediate ceasefire, NBC News reported, citing a Middle East diplomat with knowledge of the situation. When asked at a news briefing Monday about the prospect of a ceasefire, however, Israeli Prime Minister Benjamin Netanyahu indicated he was not interested in one, according to NBC News. Netanyahu said Israel is "not backing down" from eliminating Iran's nuclear program. Regardless of how negotiations — or the lack thereof — play out, it's clear that countries are placing renewed emphasis on defense. The U.S. Defense Department is turning to artificial intelligence to bolster its forces, announcing on Monday a one-year contract with OpenAI "to address critical national security challenges in both warfighting and enterprise domains." Amid the Monday developments regarding armed conflict and defense considerations, the Trump Organization announced a mobile phone plan called Trump Mobile and a smartphone, clad in gold and emblazoned with an American flag, dubbed "T1." Putting aside iffy ethical issues about the sitting U.S. president lending his name to consumer products, their unveiling seemed ill-timed and tone deaf. Perhaps the reception over Trump Mobile was spotty. Markets in America riseU.S. stocks rose Monday on news that Iran is reportedly seeking a ceasefire with Israel. The S&P 500 was up 0.94%, the Dow Jones Industrial Average climbed 0.75% and the Nasdaq Composite jumped 1.52%. Asia-Pacific markets were mixed in choppy trading Tuesday. Japan's Nikkei 225 rose 0.53% at 2:30 p.m. local time on developments regarding the country's monetary policy. G7 leaders blame Iran for 'terror'"We reiterate our support for the security of Israel," Group of Seven leaders said in a joint statement Tuesday, as Tel Aviv trades military strikes with Tehran for the fourth consecutive day. The group condemned Iran for being the "principal source of regional instability and terror," reiterating that Iran can never have a nuclear weapon. Trump will be leaving the summit a day earlier because of the Middle East conflict, the White House said Monday. BOJ to slow bond purchase cuts in 2026At its monetary policy meeting on Tuesday, the Bank of Japan reiterated it would continue reducing its monthly purchases of Japanese government bonds until March 2026, and subsequently slow down the cuts. The BOJ kept its benchmark rate unchanged at 0.5%, as expected by a Reuters poll of economists. In other Japan news, CNBC's Lim Hui Jie explores why the country, famous for its pacifist Constitution, is doubling down on arms exports. OpenAI wins contract from Defense DepartmentOpenAI has been awarded a $200 million one-year contract to provide the U.S. Defense Department with artificial intelligence tools, the latter announced Monday. It's the first contract with OpenAI listed on the Department of Defense's website. In December, OpenAI said it would collaborate with defense technology startup Anduril to deploy advanced AI systems for "national security missions." Trump Organization enters telecommunicationsThe Trump Organization, a company owned by the current U.S. President, on Monday announced a mobile phone plan and a $499 smartphone set to launch in September. The company's new foray into telecommunications mainly comprises a licensing agreement. On Friday, the president reported that he had made more than $8 million in 2024 from various licensing agreements. [PRO] What would it take for markets to react?Equity and energy markets appeared to shake off concerns of a wider conflict in the Middle East on Monday, reversing some of the moves from late last week. Such a response to geopolitical conflict is not unusual, according to one strategist, who explained what it would take for markets to feel the effects of the hostilities. Gold outshines Treasurys, yen and Swiss franc as the ultimate safe haven Gold has claimed the safe haven crown. With spot prices surging 30% so far in 2025, bullion's gains are outpacing that of other traditional safe havens such as the Japanese yen, Swiss franc, and U.S. Treasurys — compelling investors to rethink what true safety looks like in the face of fiscal sustainability concerns and looming wars. At the heart of gold's appeal is its freedom from government liabilities, market experts gathered at the annual Asia Pacific Precious Metals Conference told CNBC on Monday. "Gold's key advantage is that it is no one else's liability," said Nikos Kavalis, managing director at Metals Focus. "When an investor owns Treasurys, other sovereign bonds and even currencies, they are ultimately buying into the respective economy," he said.


Axios
39 minutes ago
- Axios
Birdie's Arjav Ezekiel takes home James Beard
Birdie's co-owner and wine pro Arjav Ezekiel beat out talent from across the country to take home a prestigious James Beard Award on Monday. Why it matters: The Beards are like the Oscars for the American hospitality industry, and win can be a huge boost in business for restaurants. Driving the news: Ezekiel won in the new Outstanding Professional in Beverage Service category. It's one of three new categories focused on beverages at the James Beard Awards. What they're saying:"It feels like a big win for our city," Ezekiel told Axios at the ceremony in Chicago. "I think people assume Austin is a cocktail city, but we're very fast becoming a wine city." Between the lines: Birdie's continues to be a standout in Austin's culinary scene, and Ezekiel was Austin's only finalist at this year's awards. The restaurant's chef and co-owner, Tracy Malechek-Ezekiel, was a finalist in the Best Texas Chef category last year. Zoom out: Houston's Belly of the Beast chef Thomas Bille nabbed the title of Best Chef in Texas, beating out four other finalists in the regional category.